WHO ICTRP trial
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a…
EUCTR2012-003559-13-SI · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003559-13-SI |
|---|---|
| Public title | Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD). |
| Scientific title | Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD). International, multicenter, double-blind, randomized, parallel group… |
| Primary sponsor | Institut de Recherches Internationales Servier |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Slovakia;Slovenia;Thailand;Spain;Turkey;Russian Federation;Colombia;Vietnam;Czech Republic;Mexico;Argentina;Brazil;Malaysia;Romania |
| Conditions | Patients suffering from symptomatic Chronic Venous Disease (CVD). MedDRA version: 14.1 Level: LLT Classification code 10066682 Term: Chronic venous insufficiency System Organ Class: 100000004866 ;Therapeutic area: Diseases [C]… |
| Interventions | Product Name: Micronized purified flavonoid fraction Product Code: S05682 Pharmaceutical Form: Oral suspension in sachet INN or Proposed INN: Micronized purified flavonoid fraction CAS Number: 111804-73-0 Concentration unit: mg milligram(s)… |
| Registration date | Apr 16, 2013 |
| Target size | 952 |
| Secondary IDs | CL3-05682-105 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: